Literature DB >> 15561484

Postgastrectomy polyneuropathy with thiamine deficiency is identical to beriberi neuropathy.

Haruki Koike1, Masahiro Iijima, Keiko Mori, Naoki Hattori, Hiroki Ito, Masaaki Hirayama, Gen Sobue.   

Abstract

OBJECTIVE: We assessed whether postgastrectomy polyneuropathy associated with thiamine deficiency is clinicopathologically identical to beriberi neuropathy, including a biochemical determination of thiamine status.
METHODS: Clinicopathologic features of 17 patients who had postgastrectomy polyneuropathy with thiamine deficiency were compared with those of 11 patients who had thiamine-deficiency neuropathy caused by dietary imbalance.
RESULTS: The typical presentation for the two etiologies was as a symmetric sensorimotor polyneuropathy predominantly involving the lower limbs. A variety of clinical features, including neuropathic symptoms, progression, and coexistence of heart failure or Wernicke's encephalopathy, was seen similarly in both conditions. In both groups, the main electrophysiologic findings were those of axonal neuropathy, most prominently in the lower limbs. Sural nerve biopsy specimens also indicated axonal degeneration in both groups. Subperineurial edema was commonly observed.
CONCLUSION: This study showed that thiamine-deficiency neuropathies due to gastrectomy and dietary imbalance are identical despite variability in their clinicopathologic features and suggested that thiamine deficiency can be a major cause of postgastrectomy polyneuropathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15561484     DOI: 10.1016/j.nut.2004.08.002

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  14 in total

1.  Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci.

Authors:  Haruki Koike; Yuichi Kawagashira; Masahiro Iijima; Masahiko Yamamoto; Naoki Hattori; Fumiaki Tanaka; Masaaki Hirayama; Yukio Ando; Shu-ichi Ikeda; Gen Sobue
Journal:  J Neurol       Date:  2008-09-24       Impact factor: 4.849

2.  Non-alcoholic Wernicke's encephalopathy with cortical involvement and polyneuropathy following gastrectomy.

Authors:  Wei-Chia Tsao; Long-Sun Ro; Chiung-Mei Chen; Hong-Shiu Chang; Hung-Chou Kuo
Journal:  Metab Brain Dis       Date:  2017-06-28       Impact factor: 3.584

Review 3.  Alcoholic neuropathy: possible mechanisms and future treatment possibilities.

Authors:  Kanwaljit Chopra; Vinod Tiwari
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

Review 4.  Interrelationships of undernutrition and neurotoxicity: food for thought and research attention.

Authors:  Peter S Spencer; Valerie S Palmer
Journal:  Neurotoxicology       Date:  2012-02-28       Impact factor: 4.294

5.  Subacute sensory ataxia and optic neuropathy with thiamine deficiency.

Authors:  Marco Spinazzi; Corrado Angelini; Cesare Patrini
Journal:  Nat Rev Neurol       Date:  2010-03-23       Impact factor: 42.937

Review 6.  Nutritional neuropathies.

Authors:  Nancy Hammond; Yunxia Wang; Mazen M Dimachkie; Richard J Barohn
Journal:  Neurol Clin       Date:  2013-05       Impact factor: 3.806

7.  Experimental alcohol-related peripheral neuropathy: role of insulin/IGF resistance.

Authors:  Van Anh Nguyen; Tran Le; Ming Tong; Michelle Mellion; James Gilchrist; Suzanne M de la Monte
Journal:  Nutrients       Date:  2012-08-17       Impact factor: 5.717

8.  Treatment considerations in neuropathic pain.

Authors:  Raphael J Leo
Journal:  Curr Treat Options Neurol       Date:  2006-09       Impact factor: 3.972

9.  Wernicke's Encephalopathy, Wet Beriberi, and Polyneuropathy in a Patient with Folate and Thiamine Deficiency Related to Gastric Phytobezoar.

Authors:  Nuria Huertas-González; Virgilio Hernando-Requejo; Zaida Luciano-García; Juan Luis Cervera-Rodilla
Journal:  Case Rep Neurol Med       Date:  2015-11-30

10.  A review of the biochemistry, metabolism and clinical benefits of thiamin(e) and its derivatives.

Authors:  Derrick Lonsdale
Journal:  Evid Based Complement Alternat Med       Date:  2006-03       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.